CPA Welcomes Preliminary Commerce Department Ruling on Solar Imports

CPA Welcomes Preliminary Commerce Department Ruling on Solar Imports

This decision represents a significant step toward protecting American solar manufacturers and the billions of dollars in U.S. investments at risk from China’s predatory and illegal trade practices.

What to Expect From U.S.-Mexico Relations Under New President Sheinbaum

What to Expect From U.S.-Mexico Relations Under New President Sheinbaum

Claudia Sheinbaum, who won Mexico’s June presidential election with 59% of the vote, will take office in October 2024. She succeeds President Andrés Manuel López Obrador (AMLO) and shares his political affiliation as a member of the National Regeneration Movement (MORENA).

China Restricts Exports of Key Minerals Used in Making Ammo, Semiconductors

China Restricts Exports of Key Minerals Used in Making Ammo, Semiconductors

If anyone needed yet another example of the importance of China miners and processing companies, Beijing said it would put restrictions on exports of antimony and processing equipment used in batteries and as an alloy to increase a metal’s strength.

U.S. Aluminum Industry Undermined by Dumping, Import Flood, and Trade Agreement Violations

U.S. Aluminum Industry Undermined by Dumping, Import Flood, and Trade Agreement Violations

Aluminum imports into the U.S. have surged in recent years, with some product categories seeing a 380% increase since 2015. Many countries have already been found guilty of dumping aluminum into the U.S. at artificially low prices.

Drug Shortages Increase Odds Of Patient Death; More Than Half of Drugs In Short Supply For Over 12 Months.

Drug Shortages Increase Odds Of Patient Death; More Than Half of Drugs In Short Supply For Over 12 Months.

Drug shortages are becoming commonplace in the U.S. Data from a new pharmaceutical industry tracking firm, Qyobo, shows hundreds of drugs are still in short supply – some well over a year — and our dependence on imports grows, including from labs on the receiving end of lackluster FDA inspections.